Glycorex Transplantation AB (publ)

Glycorex Transplantation AB (publ)

Medical-Equipment-Manufacturing

Lund, Skåne
Sweden
Company Tagline

Optimizing blood for life – solutions for improved quality of life and better health economy

Industry Category
Medical-Equipment-Manufacturing
Company Description

Glycorex Transplantation AB (publ) is a globally recognized medical technology company dedicated to optimizing blood for life, providing solutions that improve quality of life and enhance the health economy. Headquartered in Lund, Skåne, Sweden, Glycorex Transplantation AB (publ) possesses unique expertise in biologically active carbohydrates and extracorporeal blood treatment.

Located at Scheelevägen 27, Lund, Skåne 223 63, Lund, SE, Glycorex Transplantation AB (publ) focuses on developing innovative medical technologies, including its proprietary Glycosorb® ABO device. This groundbreaking innovation facilitates blood group-incompatible transplantation and transfusion by specifically reducing blood group antibodies and autoantibodies in the blood. Glycorex's focus areas encompass transplantation, blood transfusion, and autoimmune diseases.

Since 2001, Glycorex Transplantation AB (publ) has been listed on NGM Main Regulated Equity (Nordic Growth Market). The company remains committed to advancing medical science and improving patient outcomes through its cutting-edge research and product development. We invite the manager of Glycorex Transplantation AB (publ) to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements.

Glycorex Transplantation AB (publ) är ett globalt erkänt medicintekniskt företag dedikerat till att optimera blod för livet och tillhandahålla lösningar som förbättrar livskvaliteten och förstärker hälsoekonomin. Med huvudkontor i Lund, Skåne, Sverige, besitter Glycorex Transplantation AB (publ) en unik expertis inom biologiskt aktiva kolhydrater och extrakorporeal blodbehandling.

Beläget på Scheelevägen 27, Lund, Skåne 223 63, Lund, SE, fokuserar Glycorex Transplantation AB (publ) på att utveckla innovativa medicinska teknologier, inklusive sin egen Glycosorb® ABO-enhet. Denna banbrytande innovation underlättar blodgruppsinokompatibel transplantation och transfusion genom att specifikt minska blodgruppsantikroppar och autoantikroppar i blodet. Glycorex fokusområden omfattar transplantation, blodtransfusion och autoimmuna sjukdomar.

Sedan 2001 har Glycorex Transplantation AB (publ) varit noterat på NGM Main Regulated Equity (Nordic Growth Market). Företaget är fortsatt engagerat i att främja medicinsk vetenskap och förbättra patientresultat genom sin banbrytande forskning och produktutveckling. Vi inbjuder chefen för Glycorex Transplantation AB (publ) att skapa en anpassad och exklusiv företagspresentation och produktlista på vår plattform för att ytterligare belysa deras prestationer.

Key Personnel / Employees
Roland Frösing Joakim Jagorstrand Fredrik Johansson Susanne Billing

Similar Companies

Other organizations in the same industry

SternMed GmbH
Medical-Equipment-Manufacturing

Medical Device Manufacturer for Turnkey Project: Medical Imaging , Operating Room and ICU equipment

Ravensburg, Baden-Wu...
THERA-Trainer - medica Medizintechnik
Medical-Equipment-Manufacturing

LIFE IN MOTION - Our promise to all of those who need it most.

IronHorse Prime, LLC
Medical-Equipment-Manufacturing
Chicago, IL
United States
Sunfox Technologies
Medical-Equipment-Manufacturing

Redefining Cardiac Care for the world with portable ECG devices

Dehradun, Uttarakhan...
India

Alternative Company Names

This company is also known as

Glycorex Transplantation AB (publ) 糖蛋白移植AB(publ) ग्लाइकोरेक्स ट्रांसप्लांटेशन एबी (पब्ल) جليكوريكس ترانسبلانتشن إيه بي (بابليك) Гликорекс Трансплантация AB (публ) Glycorex Transplantação AB (publ)